GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Ltd (ASX:AVR) » Definitions » Other Operating Expense

Anteris Technologies (ASX:AVR) Other Operating Expense : A$13.68 Mil (TTM As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Anteris Technologies Other Operating Expense?

Anteris Technologies's Other Operating Expense for the six months ended in Dec. 2023 was A$7.79 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$13.68 Mil.

Anteris Technologies's quarterly Other Operating Expense increased from Dec. 2022 (A$5.77 Mil) to Jun. 2023 (A$5.88 Mil) and increased from Jun. 2023 (A$5.88 Mil) to Dec. 2023 (A$7.79 Mil).

Anteris Technologies's annual Other Operating Expense increased from Dec. 2021 (A$6.65 Mil) to Dec. 2022 (A$13.15 Mil) and increased from Dec. 2022 (A$13.15 Mil) to Dec. 2023 (A$13.68 Mil).


Anteris Technologies Other Operating Expense Historical Data

The historical data trend for Anteris Technologies's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anteris Technologies Other Operating Expense Chart

Anteris Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.15 6.34 6.65 13.15 13.68

Anteris Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 7.38 5.77 5.88 7.79

Anteris Technologies Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$13.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anteris Technologies Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Anteris Technologies's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Anteris Technologies (ASX:AVR) Business Description

Traded in Other Exchanges
Address
Level 3, 9 Sherwood Road, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066
Anteris Technologies Ltd is a structural heart company engaged in delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. The group's solutions include Anteris' DurAVR transcatheter heart valve for younger patients who need a heart valve that will last their lifetime, as well as DurAVR with its biomimetic design that replicates the normal blood flow of a healthy human aortic valve. The company derives key revenue from Australia and the U.S.

Anteris Technologies (ASX:AVR) Headlines

No Headlines